mHealth-supported Skills Training for Alcohol-Related Suicidality Phase 3
Launched by DUKE UNIVERSITY · Apr 27, 2023
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new intervention called mHealth-supported Skills Training for Alcohol-Related Suicidality (mSTARS) to help individuals who have thoughts of suicide and misuse alcohol. Researchers know that people who struggle with both issues are at a higher risk of attempting suicide, especially in the month after being discharged from the hospital. The goal of this study is to see if mSTARS can help these patients by providing support and skills to manage their feelings and behaviors after they leave the hospital.
To participate in this trial, individuals need to be at least 18 years old, have been hospitalized for a suicide crisis, and show signs of heavy drinking. They should also have a smartphone and be comfortable speaking English. Participants will be randomly assigned to one of three groups: one will receive the mSTARS training, another will get standard care, and the last will get standard care plus skills training. The study aims to find out how well this new approach works for patients and if they find it helpful. If you or someone you know fits these criteria, this trial could offer important resources for managing alcohol use and suicidal thoughts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18+
- • hospitalized for suicide crisis at Duke BHIP
- • an AUDIT-C score indicating hazardous past-month drinking (4 for men; 3 for women) + a 90-day calendar timeline follow-back (TLFB) indicating a minimum of 3 heavy drinking days per week on average (per NIAAA standards)
- • owns a smart phone
- • fluent in English.
- Exclusion Criteria:
- • current psychotic or mania symptoms indicated by the MINI Neuropsychiatric Interview 6.0.(MINI)
- • receiving ECT at the time of hospitalization, which could inhibit learning
- • engaged in weekly outpatient psychotherapy
- • discharging to another high level of psychiatric care.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported